Ascendis Pharma AS (STU:A71) FCF Yield % : -3.34 (As of Apr. 22, 2025)

View and export this data going back to 2017. Start your Free Trial

What is Ascendis Pharma AS FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ascendis Pharma AS's Trailing 12-Month Free Cash Flow is €-307.6 Mil, and Market Cap is €8,708.3 Mil. Therefore, Ascendis Pharma AS's FCF Yield % for today is -3.34%.

The historical rank and industry rank for Ascendis Pharma AS's FCF Yield % or its related term are showing as below:

STU:A71' s FCF Yield % Range Over the Past 10 Years
Min: -18.48 Med: -6.44 Max: -2.92
Current: -3.34

During the past 13 years, the highest FCF Yield % of Ascendis Pharma AS was -2.92%. The lowest was -18.48%. And the median was -6.44%.

STU:A71's FCF Yield % is ranked better than
73.16% of 1498 companies
in the Biotechnology industry
Industry Median: -15.525 vs STU:A71: -3.34

Ascendis Pharma AS's FCF Margin % for the quarter that ended in Dec. 2024 was -50.35%.

Ascendis Pharma AS FCF Yield % Historical Data

The historical data trend for Ascendis Pharma AS's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS FCF Yield % Chart

Ascendis Pharma AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-4.10

-6.75

-8.04

-7.34

-3.98

Ascendis Pharma AS Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															-2.65	-5.32	-3.47	-2.89	-4.54

Competitive Comparison of Ascendis Pharma AS's FCF Yield %

For the Biotechnology subindustry, Ascendis Pharma AS's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Ascendis Pharma AS FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ascendis Pharma AS's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-307.624	/	7719.876
	=	-3.98%

Ascendis Pharma AS's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-87.559	*	4	/	7719.876
	=	-4.54%

Ascendis Pharma AS FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Ascendis Pharma AS FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (STU:A71) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

ASND:USA ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

https://www.ascendispharma.com

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines